HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- (azetidin- 2- ylmethoxy)- 5- (phenylethynyl)pyridine

desensitizes alpha4beta2 nicotinic receptors; structure in first source

Also Known As:

VMY-2-95

Networked: 5 relevant articles (3 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 3-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine: 5
  - Azetines
    - Azetidines: 6
      - 3-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine: 5

Experts

1.	Brown, Milton L: 2 articles (09/2017 - 10/2013)
2.	Kellar, Kenneth J: 2 articles (09/2017 - 10/2013)
3.	Levin, Edward D: 2 articles (09/2017 - 10/2013)
4.	Liu, Yong: 2 articles (09/2017 - 10/2013)
5.	Rezvani, Amir H: 2 articles (09/2017 - 10/2013)
6.	Xiao, Yingxian: 2 articles (09/2017 - 10/2013)
7.	Du, Guanhua: 1 article (07/2021)
8.	Kong, Dewen: 1 article (07/2021)
9.	Liang, Yu: 1 article (07/2021)
10.	Yu, Ziru: 1 article (07/2021)

Related Diseases

1.	Wounds and Injuries (Trauma) 08/01/2023 - "Erratum: Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913]." 02/01/2023 - "Erratum: Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11(2021) 1903-1913]." 07/01/2021 - "Therefore, we preliminarily proved that VMY-2-95 had protective effects in depressed mice and SH-SY5Y cells against injuries induced by corticosterone. " 07/01/2021 - "Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models."
2.	Hypothermia 10/15/2013 - "Three other novel nicotinic receptor desensitizing agents derived from sazetidine-A, triazetidine-O, VMY-2-95 and YL-1-127 also produced hypothermia in WT and α7(-/-) mice. "
3.	Body Weight (Weight, Body) 09/01/2017 - "The same rats were also implanted subcutaneously with osmotic minipumps to continually deliver 2 or 6 mg/kg body weight YL-2-203, VMY-2-95, or saline for four consecutive weeks. "

Related Drugs and Biologics

1.	Corticosterone
2.	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
3.	sazetidine-A
4.	YL-2-203